Clinical research units provide a safe environment to conduct clinical trials that lead to new advancements in healthcare modalities for patients. Many regulations govern the conduct of clinical trials with human subjects, and with regulations come many ways in which research units have to report any event that is potentially related to the intervention being tested. These reports are classified as either adverse events or serious adverse event reports. An adverse event is a side effect that may be harmful and/or caused by the intervention.1 An adverse event can be either an observed event that is partially or entirely due to the intervention or totally unrelated to the intervention, but still occurring while the intervention is being tested.1 Adverse event reporting consumes time for all involved in the research process, i.e., nursing staff, principal investigators, and sponsors. The time to complete the paperwork is a cost not only to the research team, but to subjects as well. The principal investigator spends hours following up with the subject and team, determining if the adverse event was related to the intervention, and then completing documentation supporting the decision. This process, while important, can prolong the trial for weeks and may be completely unrelated to the actual intervention. Decreasing the number of adverse events, such as contact dermatitis secondary to electrocardiogram (ECG) electrodes, can also decrease the amount of time, money, and the discomfort to the participant during the conduct of research trials.